Paper Details

  1. Home
  2. Paper Details

Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group.

Author: ShenMeilong, SunXiaojun, WangBian, WangChengwei, XuHongtao, YangXiuzhen, ZhuKuichun

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study investigated the efficacy of nucleotide/nucleoside analogues and hepatitis B immunoglobulin (HBIG) in blocking mother-to-child transmission of hepatitis B virus. Results suggest that routine HBV vaccine plus HBIG is insufficient, and that administering these agents during pregnancy is crucial.
Paper Details　
Original Abstract of the Article :
The objective of this study was to investigate the efficacy and potential side-effects of nucleotide/nucleoside analogues and hepatitis B immunoglobulin injection of newborns in blocking mother-to-child transmission of hepatitis B virus in the middle and late pregnancy period. 238 cases of enrolled ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759418/

データ提供：米国国立医学図書館（NLM）

Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group

This study investigates the efficacy of nucleotide/nucleoside analogues and hepatitis B immunoglobulin (HBIG) in preventing mother-to-child transmission (MTCT) of hepatitis B virus. The research compares the effectiveness of different treatment strategies in a group of pregnant women in Eastern China.

Breaking the Chain of Hepatitis B Transmission

This research provides crucial information on preventing MTCT of hepatitis B, a significant public health concern. The study demonstrates that nucleotide/nucleoside analogues, in addition to routine vaccination and HBIG, can significantly reduce the risk of infants acquiring the virus from their mothers.

Protecting the Next Generation

This research highlights the importance of proactive measures to protect infants from infectious diseases like hepatitis B. It underscores the need for comprehensive treatment strategies that can effectively prevent MTCT and ensure a healthy start for newborns.

Dr. Camel's Conclusion

This study emphasizes the importance of effective interventions to break the cycle of infectious diseases. Like a desert caravan carefully navigating a treacherous path, healthcare professionals are constantly searching for ways to protect vulnerable populations, such as infants, from preventable diseases. This research underscores the importance of ongoing research and innovation in developing effective preventive measures.

Date :
  1. Date Completed 2021-06-01
  2. Date Revised 2021-06-01
Further Info :

Pubmed ID

33380780

DOI: Digital Object Identifier

PMC7759418

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.